Zavation Medical’s acquisition of ChoiceSpine looks like a strategically sound step within the ongoing consolidation of the spine mid-market. With private equity firm Gemspring Capital behind the deal, the rationale is familiar: bring together complementary platforms, expand commercial reach, improve EBITDA potential, and ultimately build a more … [Read More...] about Behind the Deal: The Strategic Logic of Zavation’s ChoiceSpine Acquisition
Main Content
BREAKING NEWS
Zavation Acquires ChoiceSpine, Names Derek Kuyper CEO of Combined Company
FLOWOOD, Miss., Feb. 26, 2026 /PRNewswire/ -- Zavation Medical Products, LLC ("Zavation"), a portfolio company of Gemspring Capital and designer and manufacturer of spinal implants, interventional spine products, and biologics, announced today that it has acquired Choice Spine Holdings, Inc. ("ChoiceSpine"), a designer and manufacturer of spinal implant systems based in Knoxville, … [Read More...] about Zavation Acquires ChoiceSpine, Names Derek Kuyper CEO of Combined Company
Smith+Nephew signs distribution agreement with SI-BONE
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced it has signed a distribution agreement with SI-BONE, focused on their innovative iFuse TORQ portfolio. This collaboration expands the Smith+Nephew portfolio offerings for percutaneous pelvic fracture fixation procedures and strengthens our position in high-frequency, high-impact trauma procedures. “We’re … [Read More...] about Smith+Nephew signs distribution agreement with SI-BONE
4WEB Medical Receives 510(k) Clearance to Market its New SI Joint Truss System™
DALLAS, Feb. 25, 2026 /PRNewswire/ -- 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary TRUSS Implant Technology™, announced that it has received 510(k) clearance to market its SI Joint Truss System™. 4WEB's SI Joint Truss System is indicated for fusion of the sacroiliac joint for sacroiliac joint dysfunction including … [Read More...] about 4WEB Medical Receives 510(k) Clearance to Market its New SI Joint Truss System™
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin … [Read More...] about Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
Amplify Surgical®, Inc. Hosts 5th Annual Endoscopic Spine Symposium with Cadaver Labs – featuring dualPortal®2.0 Endoscopic and dualX®Slim Technologies
Amplify Surgical will be hosting the 5th Annual Endoscopic Spine Symposium, featuring dualPortal and dualXSlim Technologies, in Orange, CA on March 21st, 2026. ORANGE, Calif., Feb. 24, 2026 /PRNewswire-PRWeb/ -- Amplify Surgical, Inc., specializes in ultra minimally invasive lumbar spine solutions, announces its highly anticipated 5th Annual Endoscopic Spine Symposium … [Read More...] about Amplify Surgical®, Inc. Hosts 5th Annual Endoscopic Spine Symposium with Cadaver Labs – featuring dualPortal®2.0 Endoscopic and dualX®Slim Technologies
From Niche to Momentum: The Rapid Rise of Spinal Endoscopy — A Brief Market Update
With ESUBE's second masterclass taking place tomorrow (February 26–28, 2026), in Seville, Spain, it's worth looking at just how much spinal endoscopy has evolved. More hospitals are adopting these techniques, and there's been significant investment in research, what was once a highly specialized procedure is gradually becoming more routine in spine surgery. In this brief update, we take a … [Read More...] about From Niche to Momentum: The Rapid Rise of Spinal Endoscopy — A Brief Market Update
ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2025, and business highlights. Fourth Quarter and Full-Year 2025 Financial Results Fourth Quarter … [Read More...] about ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results
Globus Medical Reports Fourth Quarter and Full Year 2025 Results
AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025: Full Year 2025: “Momentum built throughout 2025 accelerated in the fourth quarter, capping off a strong finish to the year with … [Read More...] about Globus Medical Reports Fourth Quarter and Full Year 2025 Results
We are proud to announce that A-Spine will once again be a sponsor of SPINEMarketGroup in 2026
Thank you, A-SPINE! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About A-SPINE The leading spine medical device brand in Taiwan A-SPINE Asia Co., Ltd. (A-SPINE) was founded in 2001. It is the first company in Taiwan to focus on the … [Read More...] about We are proud to announce that A-Spine will once again be a sponsor of SPINEMarketGroup in 2026
Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2025, provided full-year 2026 financial guidance and updated its three-year financial targets. All pro forma measures contained within this release exclude the impact of the Company’s … [Read More...] about Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance